Menopause Hormone Therapy

Halle Berry Slams Newsom for “Devaluing Women” Before His Appearance

Speaking at The New York Times’ DealBook Summit, Halle Berry criticized California Governor Gavin Newsom for vetoing a menopause care bill for the second year in a row. Berry, who is a strong advocate for women’s health and the founder of wellness company Respin Health, expressed her disappointment, emphasizing the devaluation of women in midlife within society. Newsom’s office later clarified the veto was due to concerns about potentially increasing healthcare costs for working women. Berry’s remarks occurred shortly before Newsom himself was scheduled to speak at the same event.

Read More

FDA Hormone Therapy Warnings Lifted: Skepticism and the Road Ahead

The Food and Drug Administration (FDA) is removing black box safety warnings from hormone therapy treatments for menopause, citing a review of recent scientific evidence. The warnings, which previously highlighted risks of cancer, dementia, heart attacks, and strokes, will be removed to increase accessibility and facilitate shared decision-making between patients and clinicians. Despite this change, systemic estrogen products still carry potential risks, and the American College of Obstetrics and Gynecology (ACOG) emphasizes the importance of individual consultations. The FDA’s decision, however, has drawn some criticism, as it bypassed the usual advisory committee process.

Read More